title: Chromosomal instability in the lymphocytes of breast cancer patients.
abstract: Genomic instability in the tumor tissue has been correlated with tumor progression. In the present study, chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) of breast tumor patients were studied to assess whether chromosomal instability (CIN) in PBLs correlates with aggressiveness of breast tumor (i.e., disease stage) and has any prognostic utility. Cultured blood lymphocyte metaphases were scored for aberrations in 31 breast cancer patients and 20 healthy age and sex-matched controls. A variety of CAs, including aneuploidy, polyploidy, terminal deletions, acentric fragments, double minutes, chromatid separations, ring chromosome, marker chromosome, chromatid gaps, and breaks were seen in PBLs of the patients. The CAs in patients were higher than in controls. A comparison of the frequency of metaphases with aberrations by grouping the patients according to the stage of advancement of disease did not reveal any consistent pattern of variation in lymphocytic CIN. Neither was any specific chromosomal abnormality found to be associated with the stage of cancer. This might be indicative of the fact that cancer patients have constitutional CIN, which predisposes them to the disease, and this inherent difference in the level of genomic instability might play a role in disease progression and response to treatment.
authors.affiliation: Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab-143 005, India.
authors.forename: Kaur
authors.initials: K
authors.lastname: Harsimran
authors.forename: Monga Gaganpreet
authors.initials: MG
authors.lastname: Kaur
authors.forename: Setia
authors.initials: S
authors.lastname: Nitika
authors.forename: Sudan
authors.initials: S
authors.lastname: Meena
authors.forename: Uppal
authors.initials: U
authors.lastname: M S
authors.lastname: Yamini
authors.forename: Batra
authors.initials: B
authors.lastname: A P S
authors.forename: Sambyal
authors.initials: S
authors.lastname: Vasudha
references.citation: Oncol Rep. 2001 Sep-Oct;8(5):1001-5
references.pmid: 11496305
references.citation: Anticancer Res. 1991 May-Jun;11(3):1055-60
references.pmid: 1888138
references.citation: Trends Cell Biol. 1999 Dec;9(12):M57-60
references.pmid: 10611684
references.citation: Epidemiology. 2004 Jul;15(4):442-50
references.pmid: 15232405
references.citation: Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):533-7
references.pmid: 11173151
references.citation: BMJ. 2000 Sep 9;321(7261):624-8
references.pmid: 10977847
references.citation: Environ Health Perspect. 2005 May;113(5):517-20
references.pmid: 15866756
references.citation: Cytogenet Genome Res. 2004;104(1-4):376-82
references.pmid: 15162068
references.citation: Ann Genet. 1994;37(4):192-5
references.pmid: 7710254
references.citation: J Cell Biol. 2008 Feb 25;180(4):665-72
references.pmid: 18283116
references.citation: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5770-5
references.pmid: 11296254
references.citation: Hum Genet. 1991 Nov;88(1):39-41
references.pmid: 1959924
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):783-9
references.pmid: 9752986
references.citation: Nat Rev Cancer. 2001 Nov;1(2):109-17
references.pmid: 11905802
references.citation: Cancer. 1999 Jun 1;85(11):2400-9
references.pmid: 10357411
references.citation: Ann Surg. 2001 Dec;234(6):795-802; discussion 802-3
references.pmid: 11729386
references.citation: Mutat Res. 2008 Mar 12;651(1-2):93-104
references.pmid: 18093868
references.citation: Environ Health Perspect. 1993 Oct;101 Suppl 3:169-75
references.pmid: 7511527
references.citation: Am J Epidemiol. 2007 Jan 1;165(1):36-43
references.pmid: 17071846
references.citation: Nat Genet. 2004 Sep;36(9):984-8
references.pmid: 15300252
references.citation: Hum Pathol. 2000 Feb;31(2):201-7
references.pmid: 10685634
references.citation: Nat Rev Cancer. 2004 Apr;4(4):266-76
references.pmid: 15057286
references.citation: Exp Cell Res. 1960 Sep;20:613-6
references.pmid: 13772379
references.citation: Breast Cancer Res Treat. 1998 Mar;48(2):187-90
references.pmid: 9596490
references.citation: Epidemiol Rev. 1993;15(1):36-47
references.pmid: 8405211
references.citation: Cancer Res. 2004 Mar 15;64(6):2258-63
references.pmid: 15026371
references.citation: Int J Oncol. 2000 Aug;17(2):399-404
references.pmid: 10891553